473 related articles for article (PubMed ID: 19064999)
1. The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis.
Rader DJ; Alexander ET; Weibel GL; Billheimer J; Rothblat GH
J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S189-94. PubMed ID: 19064999
[TBL] [Abstract][Full Text] [Related]
2. LDL Receptor Regulates the Reverse Transport of Macrophage-Derived Unesterified Cholesterol via Concerted Action of the HDL-LDL Axis: Insight From Mouse Models.
Cedó L; Metso J; Santos D; García-León A; Plana N; Sabate-Soler S; Rotllan N; Rivas-Urbina A; Méndez-Lara KA; Tondo M; Girona J; Julve J; Pallarès V; Benitez-Amaro A; Llorente-Cortes V; Pérez A; Gómez-Coronado D; Ruotsalainen AK; Levonen AL; Sanchez-Quesada JL; Masana L; Kovanen PT; Jauhiainen M; Lee-Rueckert M; Blanco-Vaca F; Escolà-Gil JC
Circ Res; 2020 Aug; 127(6):778-792. PubMed ID: 32495699
[TBL] [Abstract][Full Text] [Related]
3. Foam cells in atherosclerosis.
Yu XH; Fu YC; Zhang DW; Yin K; Tang CK
Clin Chim Acta; 2013 Sep; 424():245-52. PubMed ID: 23782937
[TBL] [Abstract][Full Text] [Related]
4. Reverse cholesterol transport and cholesterol efflux in atherosclerosis.
Ohashi R; Mu H; Wang X; Yao Q; Chen C
QJM; 2005 Dec; 98(12):845-56. PubMed ID: 16258026
[TBL] [Abstract][Full Text] [Related]
5. Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo.
Wang X; Collins HL; Ranalletta M; Fuki IV; Billheimer JT; Rothblat GH; Tall AR; Rader DJ
J Clin Invest; 2007 Aug; 117(8):2216-24. PubMed ID: 17657311
[TBL] [Abstract][Full Text] [Related]
6. [Role of HDL in Cholesterol Efflux and Reverse Cholesterol Transport].
Ayaori M
Rinsho Byori; 2016 Jan; 64(1):57-65. PubMed ID: 27192798
[TBL] [Abstract][Full Text] [Related]
7. Seeking novel targets for improving in vivo macrophage-specific reverse cholesterol transport: translating basic science into new therapies for the prevention and treatment of atherosclerosis.
Julve J; Llaverias G; Blanco-Vaca F; Escolà-Gil JC
Curr Vasc Pharmacol; 2011 Mar; 9(2):220-37. PubMed ID: 21143175
[TBL] [Abstract][Full Text] [Related]
8. ATP-binding cassette transporters A1 and G1, HDL metabolism, cholesterol efflux, and inflammation: important targets for the treatment of atherosclerosis.
Ye D; Lammers B; Zhao Y; Meurs I; Van Berkel TJ; Van Eck M
Curr Drug Targets; 2011 May; 12(5):647-60. PubMed ID: 21039336
[TBL] [Abstract][Full Text] [Related]
9. Effects of Astaxanthin on Reverse Cholesterol Transport and Atherosclerosis in Mice.
Zou TB; Zhu SS; Luo F; Li WQ; Sun XR; Wu HF
Biomed Res Int; 2017; 2017():4625932. PubMed ID: 29226138
[TBL] [Abstract][Full Text] [Related]
10. Rate-limiting factors of cholesterol efflux in reverse cholesterol transport: acceptors and donors.
Fu Y
Clin Exp Pharmacol Physiol; 2010 Jul; 37(7):703-9. PubMed ID: 20374257
[TBL] [Abstract][Full Text] [Related]
11. Hepatic Overexpression of Endothelial Lipase Lowers High-Density Lipoprotein but Maintains Reverse Cholesterol Transport in Mice: Role of Scavenger Receptor Class B Type I/ATP-Binding Cassette Transporter A1-Dependent Pathways.
Takiguchi S; Ayaori M; Yakushiji E; Nishida T; Nakaya K; Sasaki M; Iizuka M; Uto-Kondo H; Terao Y; Yogo M; Komatsu T; Ogura M; Ikewaki K
Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1454-1467. PubMed ID: 29748333
[TBL] [Abstract][Full Text] [Related]
12. Increased atherosclerosis in P2Y13/apolipoprotein E double-knockout mice: contribution of P2Y13 to reverse cholesterol transport.
Lichtenstein L; Serhan N; Espinosa-Delgado S; Fabre A; Annema W; Tietge UJ; Robaye B; Boeynaems JM; Laffargue M; Perret B; Martinez LO
Cardiovasc Res; 2015 May; 106(2):314-23. PubMed ID: 25770145
[TBL] [Abstract][Full Text] [Related]
13. Xanthohumol, a hop-derived prenylated flavonoid, promotes macrophage reverse cholesterol transport.
Hirata H; Uto-Kondo H; Ogura M; Ayaori M; Shiotani K; Ota A; Tsuchiya Y; Ikewaki K
J Nutr Biochem; 2017 Sep; 47():29-34. PubMed ID: 28501703
[TBL] [Abstract][Full Text] [Related]
14. Effect of sulfonylurea agents on reverse cholesterol transport in vitro and vivo.
Terao Y; Ayaori M; Ogura M; Yakushiji E; Uto-Kondo H; Hisada T; Ozasa H; Takiguchi S; Nakaya K; Sasaki M; Komatsu T; Iizuka M; Horii S; Mochizuki S; Yoshimura M; Ikewaki K
J Atheroscler Thromb; 2011; 18(6):513-30. PubMed ID: 21636950
[TBL] [Abstract][Full Text] [Related]
15. New insights into the regulation of HDL metabolism and reverse cholesterol transport.
Lewis GF; Rader DJ
Circ Res; 2005 Jun; 96(12):1221-32. PubMed ID: 15976321
[TBL] [Abstract][Full Text] [Related]
16. Effect of up-regulating individual steps in the reverse cholesterol transport pathway on reverse cholesterol transport in normolipidemic mice.
Alam K; Meidell RS; Spady DK
J Biol Chem; 2001 May; 276(19):15641-9. PubMed ID: 11278646
[TBL] [Abstract][Full Text] [Related]
17. Brothers in Arms: ABCA1- and ABCG1-Mediated Cholesterol Efflux as Promising Targets in Cardiovascular Disease Treatment.
Frambach SJCM; de Haas R; Smeitink JAM; Rongen GA; Russel FGM; Schirris TJJ
Pharmacol Rev; 2020 Jan; 72(1):152-190. PubMed ID: 31831519
[TBL] [Abstract][Full Text] [Related]
18. Future therapeutic directions in reverse cholesterol transport.
Khera AV; Rader DJ
Curr Atheroscler Rep; 2010 Jan; 12(1):73-81. PubMed ID: 20425274
[TBL] [Abstract][Full Text] [Related]
19. The impact of gender and serum estradiol levels on HDL-mediated reverse cholesterol transport.
Badeau RM; Metso J; Kovanen PT; Lee-Rueckert M; Tikkanen MJ; Jauhiainen M
Eur J Clin Invest; 2013 Apr; 43(4):317-23. PubMed ID: 23397902
[TBL] [Abstract][Full Text] [Related]
20. Rethinking reverse cholesterol transport and dysfunctional high-density lipoproteins.
Gillard BK; Rosales C; Xu B; Gotto AM; Pownall HJ
J Clin Lipidol; 2018; 12(4):849-856. PubMed ID: 29731282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
